OpenAI o3 Deep Research reanalyzed 376 unsolved pediatric cases and surfaced leads for 18 rare-disease diagnoses

Using AI to help physicians diagnose rare genetic diseases affecting children

Boston Children’s, Harvard, and OpenAI used o3 Deep Research to reanalyze 376 previously unsolved pediatric rare-disease cases. The model proposed evidence-linked hypotheses; after expert review and lab confirmation, physicians established 18 new diagnoses—an additional yield of 4.8%. The model never made clinical decisions. All confirmed diagnoses went through CLIA-certified lab validation. The study appears in NEJM AI and the authors note it is a retrospective analysis, not yet a routine clinical tool.

Why it matters: NEJM AI-published study: o3 deep research reanalyzed 376 unsolved pediatric rare-disease cases and surfaced 18 new diagnoses (4.8%). Has a paper, concrete numbers, and a CLIA validation pipeline — not a PR fluff piece. Held at 78 rather than 85+ because it's a single study, no...